why choose us

First received: October 20, 2022

Clinical Trial: Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hypertension

Study Type: INTERVENTIONAL


Official Title: Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Brief Summary: The investigators' goal is to show that in hypertensive men and women with left ventricular hypertrophy (LVH) treatment with a mineralocorticoid receptor (MR) antagonist, versus a thiazide-like diuretic, will improve coronary microvascular function and cardiac efficiency, which will associate with improvements in LV structure and function.The investigators will achieve this through a randomized, controlled, basic experimental study involving humans (BESH).

Read more